Histone Deacetylase Inhibitor Romidepsin Inhibits De Novo HIV-1 Infections

類似資料

• A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4(+) T Cells
  著者:: Offersen, Rasmus, 等
  出版事項: (2016)
• Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation
  著者:: Gunst, Jesper D, 等
  出版事項: (2019)
• Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses
  著者:: Brinkmann, Christel Rothe, 等
  出版事項: (2018)
• Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System
  著者:: Rasmussen, Thomas A., 等
  出版事項: (2015)
• In Vivo Administration of Histone Deacetylase Inhibitors Does Not Impair Natural Killer Cell Function in HIV+ Individuals
  著者:: GARRIDO, Carolina, 等
  出版事項: (2019)